Checkpoint Therapeutics: Funding, Investors & Team (Oct 2026)
Checkpoint Therapeutics primarily focuses on progressing the development of cancer immunotherapy and targeted oncology treatments. The company is committed to expediting the process of bringing cancer therapies to market and actively seeks out opportunities to acquire, license, or co-develop products that align with its areas of specialization. By implementing a streamlined approach, Checkpoint Therapeutics reduces risk and speeds up the development and introduction of oncology drugs, ultimately ensuring that more patients, payors, and providers have access to effective and affordable treatment options.
Checkpoint Therapeutics has raised $22.0M across 2 funding rounds on record, the most recent an undisclosed round of $12.0M announced in Jul 2024.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Checkpoint Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2024.
Checkpoint Therapeutics Funding Rounds
Checkpoint Therapeutics raised $10.0M in an undisclosed round announced in May 2023.
1.2 years later, an undisclosed round of $12.0M was announced in Jul 2024.
Checkpoint Therapeutics Founders and Leadership Team
Contact details for the Checkpoint Therapeutics team: 1 of 2 have an email address on file.
Start 14-day free trial →Checkpoint Therapeutics Funding Compared to Other Biotechnology Startups
Checkpoint Therapeutics' latest round of $12.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Checkpoint Therapeutics in Biotechnology and Waltham
Companies Similar to Checkpoint Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Checkpoint Therapeutics Funding FAQs
What does Checkpoint Therapeutics do?
Checkpoint Therapeutics primarily focuses on progressing the development of cancer immunotherapy and targeted oncology treatments. The company is committed to expediting the process of bringing cancer therapies to market and actively seeks out opportunities to acquire, license, or co-develop products that align with its areas of specialization. By implementing a streamlined approach, Checkpoint Therapeutics reduces risk and speeds up the development and introduction of oncology drugs, ultimately ensuring that more patients, payors, and providers have access to effective and affordable treatment options.
How much funding has Checkpoint Therapeutics raised?
Checkpoint Therapeutics has raised $22.0M across 2 rounds on record. The most recent is an undisclosed round of $12.0M announced in Jul 2024.
When did Checkpoint Therapeutics last raise funding?
Checkpoint Therapeutics' most recent funding round on record is an undisclosed round of $12.0M, announced in Jul 2024.
Who founded Checkpoint Therapeutics?
FundedIQ lists James Oliviero (Founder) at Checkpoint Therapeutics.
Who is the CEO of Checkpoint Therapeutics?
James F Oliviero is listed as CEO at Checkpoint Therapeutics.
Where is Checkpoint Therapeutics headquartered?
Checkpoint Therapeutics is based in Waltham, Massachusetts, United States.
How many employees does Checkpoint Therapeutics have?
Checkpoint Therapeutics is in the 11-50 employee band.
How does Checkpoint Therapeutics' funding compare to other Biotechnology startups?
Checkpoint Therapeutics' latest round of $12.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Checkpoint Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Checkpoint Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.